Pay-For-Delay Deals Stay Under Wraps In Cephalon Suit
Cephalon Inc. on Monday lost a bid to force the Federal Trade Commission to release the details of dozens of so-called pay-for-delay agreements that name-brand drugmakers used to keep generic competition...To view the full article, register now.
Already a subscriber? Click here to view full article